The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)
Filter results
| Date | Title | Content | |
|---|---|---|---|
| 28/07/2021 | On business and financial situation | The company releases the press release related to first half 2021 financial results | |
| 28/07/2021 | On business and financial situation | ROVI releases the first half 2021 results presentation | |
| 16/07/2021 | On Corporate Governance | ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company | |
| 13/07/2021 | Laboratorios Farmacéuticos Rovi regrets the passing of its President Juan López-Belmonte | The Company informs about the passing of its President Juan López-Belmonte López | |
| 5/07/2021 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the second quarter of 2021 | |
| 2/07/2021 | Other relevant information | The Company informs about the dividends payment | |
| 22/06/2021 | On significant placements in financial instruments | Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. | |
| 22/06/2021 | On significant placements in financial instruments | Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. | |
| 17/06/2021 | Announcement of general shareholders’ meeting | ROVI releases the information related to its General Shareholders Meeting | |
| 13/05/2021 | On business and financial situation | ROVI releases the first quarter 2021 results presentation |